| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stanley Division of Developmental Neurovirology, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD; Department of Chemistry and The Malaria Research Institute, Johns Hopkins University, Baltimore, MD
* To whom correspondence should be addressed. Email: lbrando{at}jhmi.edu,
| Abstract |
|---|
Toxoplasmosis, caused by the protozoan Toxoplasma gondii, is medically important and distributed worldwide. Currently available medications are limited in terms of efficacy and side effects. We synthesized novel, non-acetal, hydrolytically stable derivatives of artemisinin and showed that they inhibit the replication of Toxoplasma gondii in cell culture.
This article has been cited by other articles:
| Clin. Vaccine Immunol. | Clin. Microbiol. Rev. |
|---|---|
| J. Clin. Microbiol. | ALL ASM JOURNALS |